Factors Associated With Edoxaban Concentration Among Patients With Atrial Fibrillation
出版年份 2021 全文链接
标题
Factors Associated With Edoxaban Concentration Among Patients With Atrial Fibrillation
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-09-09
DOI
10.3389/fphar.2021.736826
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation
- (2020) Yi-Hsin Chan et al. HEART RHYTHM
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
- (2020) Ken Okumura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between plasma concentration of edoxaban determined by direct and indirect methods in Japanese patients with non-valvular atrial fibrillation (CVI ARO 7)
- (2019) Shinya Suzuki et al. HEART AND VESSELS
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial
- (2018) Giuseppe Boriani et al. EUROPEAN HEART JOURNAL
- Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial
- (2018) Tze-Fan Chao et al. EUROPEAN HEART JOURNAL
- Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialClinical Perspective
- (2016) Erin A. Bohula et al. CIRCULATION
- Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa
- (2015) Dolly A. Parasrampuria et al. CLINICAL PHARMACOKINETICS
- Laboratory measurement of the anticoagulant activity of edoxaban: a systematic review
- (2015) Adam Cuker et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of hematocrit on bioanalysis of DBS: results from the EBF DBS-microsampling consortium
- (2013) Ronald de Vries et al. Bioanalysis
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Clinical Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Factor Xa Inhibitor Edoxaban in Healthy Volunteers
- (2010) Koichiro Ogata et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started